Citation Impact
Citing Papers
How cognitive and reactive fear circuits optimize escape decisions in humans
2018 StandoutNobel
Altered fecal microbiota composition in patients with major depressive disorder
2015 Standout
Chapter 4 Affect as a Psychological Primitive
2009 Standout
Influence of circadian phase and test illumination on pre-clinical models of anxiety
2001
Nutraceuticals: Facts and fiction
2007 Standout
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Chemistry and biology of monoterpene indole alkaloid biosynthesis
2006 Standout
Measuring normal and pathological anxiety-like behaviour in mice: a review
2001
Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions
2002
Human Hippocampus Arbitrates Approach-Avoidance Conflict
2014
Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial
2008
Behavioral and genoprotective effects of Vaccinium berries intake in mice
2006
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
2007 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Sex bias in neuroscience and biomedical research
2010 Standout
Effect of lyophilised berries on memory, anxiety and locomotion in adult rats
2005
QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice
2001
Changes in anxiety-related behaviors and hypothalamic–pituitary–adrenal activity in mice lacking the 5-HT-3A receptor
2004 StandoutNobel
Slow escape decisions are swayed by trait anxiety
2019 StandoutNobel
Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety
1998
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
2003 Standout
Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice
2005
The Gerbil Elevated Plus-Maze I Behavioral Characterization and Pharmacological Validation
2002
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Anxiolytic properties of the antipsychotic alkaloid alstonine
2004
Phenotypic differences in behavior, physiology and neurochemistry between rats selected for tameness and for defensive aggression towards humans
2007 StandoutNobel
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Gut–brain axis: how the microbiome influences anxiety and depression
2013 Standout
Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation
1998
The age of anxiety: role of animal models of anxiolytic action in drug discovery
2011
Acute and Chronic Effects of Gepirone and Fluoxetine in Rats Tested in the Elevated Plus-maze
2000
The dopamine D4 receptor: biochemical and signalling properties
2010
Factor analysis of Forced Swimming test, Sucrose Preference test and Open Field test on enriched, social and isolated reared rats
2006
Individual response profiles of male Wistar rats in animal models for anxiety and depression
2002
Vicarious trial and error
2016
Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies
2001
The mouse light/dark box test
2003
Agmatine Potentiates Morphine-Induced Conditioned Place Preference in Mice: Modulation by Alpha(2)-Adrenoceptors
2005
The Mesolimbic Dopamine Reward Circuit in Depression
2006 Standout
Profile of wild Neotropical spiny rats (Trinomys, Echimyidae) in two behavioral tests
2003
Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior
2001
Major Depressive Disorder
2008 Standout
Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice
2004
Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder
2011 Standout
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze
2006
Ethopharmacological Analysis of 5-HT Ligands on the Rat Elevated Plus-Maze
1999
Neuroscience-Inspired Artificial Intelligence
2017 StandoutNobel
Behavioral syndromes: an ecological and evolutionary overview
2004 Standout
Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments
1999
Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist
2002
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Rearing on Hind Legs, Environmental Novelty, and the Hippocampal Formation
2006 StandoutNobel
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on
2005
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Involvement of GABAA-benzodiazepine receptor in the anxiolytic effect induced by hexanic fraction of Rubus brasiliensis
1998
Behavioral Syndromes: An Integrative Overview
2004 Standout
Animal models of anxiety and depression: how are females different?
2001
Longitudinal study of daily variation of rats' behavior in the elevated plus-maze
2003
Plants and the central nervous system
2003 Standout
Behavioral profile of wild mice in the elevated plus-maze test for anxiety
2000
Exercise offers anxiolytic potential: A role for stress and brain noradrenergic-galaninergic mechanisms
2012
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Anxiolytic and Sedative Effects of Extracts and Essential Oil from Citrus aurantium L.
2002
Fear and Feeding in the Nucleus Accumbens Shell: Rostrocaudal Segregation of GABA-Elicited Defensive Behavior Versus Eating Behavior
2001
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
Experimental anxiety and the reinforcing effects of ethanol in rats
1999
Works of B.-J. Cao being referenced
Tolerance to acute anxiolysis but no withdrawal anxiogenesis in mice treated chronically with 5-HT1A receptor antagonist, WAY 100635
1998
Animal models of anxiety: an ethological perspective
1997
Dopamine D4 receptor and anxiety: Behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze
1997
Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze
1997
Comparative effects of novel 5-HT 1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice
1998
Anxiolytic-like profile of p -MPPI, a novel 5HT 1A receptor antagonist, in the murine elevated plus-maze
1997
CIRCADIAN VARIATION IN ANXIOLYTIC RESPONSE TO THE 5-HT1A RECEPTOR ANTAGONIST, LY297996
1998
CIRCADIAN VARIATION IN ANXIOLYTIC RESPONSE TO THE 5-HT1A RECEPTOR ANTAGONIST, LY297996
1998